Oruka Therapeutics Stock (NASDAQ:ORKA)
Previous Close
$64.03
52W Range
$10.77 - $91.00
50D Avg
$63.31
200D Avg
$37.33
Market Cap
$2.56B
Avg Vol (3M)
$1.57M
Beta
-0.30
Div Yield
$19.36
ORKA Company Profile
Oruka Therapeutics, Inc. functions as a biotechnology firm primarily dedicated to creating groundbreaking monoclonal antibody therapies. These treatments are designed to address Psoriasis (PsO) along with various other inflammatory and immunological (I&I) conditions. Its current development portfolio includes ORKA-001 and ORKA-002. The company's main operations are based in Menlo Park, CA.